Research map: Implementation Science for Effective Risk Management of Medicines: A Call for Global Action

Back to the article

Papers in this map

  1. Standards for Reporting Implementation Studies (StaRI) Statement · Hilary Pinnock · 2017 · 1561 citations · Cited by this paper
  2. Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus Group · 2026 · Related
  3. Innovative approaches for cancer treatment: current perspectives and new challenges · Carlotta Pucci · 2019 · 821 citations · Cited by this paper
  4. A Large Language Model for Extracting Post-marketing Adverse Drug Events from Clinical Notes in the Electronic Health Record · 2026 · Related
  5. Novel approaches for vaccine development · Makda S. Gebre · 2021 · 358 citations · Cited by this paper
  6. Pharmacovigilance Through Fresh Eyes: The International Society of Pharmacovigilance Student Community's Role in Shaping the Future of Pharmacovigilance · 2026 · Related
  7. Pharmacovigilance in low‐ and middle‐income countries: A review with particular focus on Africa · Ronald Kiguba · 2021 · 138 citations · Cited by this paper
  8. Reliability of Self-Reported Maternal Health and Mother–Infant Outcome Data in Web-Based Questionnaires · 2026 · Related
  9. Therapeutic Advances in Multiple Sclerosis · Jennifer H. Yang · 2022 · 134 citations · Cited by this paper
  10. Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant · 2026 · Related
  11. Emerging Genetic Therapy for Sickle Cell Disease · Stuart H. Orkin · 2018 · 121 citations · Cited by this paper
  12. MCSG: A Method for Simultaneous Disproportionality Analysis and Background Rate Estimation in Large Pharmacovigilance Databases · 2025 · Related
  13. The Race for Global Equitable Access to COVID-19 Vaccines · Lukman Nul Hakim Md Khairi · 2022 · 79 citations · Cited by this paper
  14. Pharmacovigilance Due Diligence in Drug Development: A Practical Playbook for Risk Identification, Compliance Assessment, and Strategic Decision Making · 2025 · Related
  15. A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post‐Authorization Studies · Pareen Vora · 2018 · 47 citations · Cited by this paper
  16. US Risk Evaluation and Mitigation Strategies with Elements to Assure Safe Use: A Longitudinal Analysis of REMS Modifications (2008–2022) · 2026 · Related
  17. The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products · Meredith Y. Smith · 2017 · 37 citations · Cited by this paper
  18. GP Consultations for Herpes Zoster After COVID-19 Vaccination: A Self-Controlled Cohort Study Based on Electronic Health Record Data from the Netherlands · 2025 · Related
  19. Are risk minimization measures for approved drugs in Europe effective? A systematic review · Esther Artime · 2019 · 36 citations · Cited by this paper
  20. Benefit–Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist · Christine Radawski · 2015 · 28 citations · Cited by this paper
  21. Risk Management for the 21st Century: Current Status and Future Needs · Rania Mouchantaf · 2021 · 26 citations · Cited by this paper
  22. Where Is the Implementation Science? An Opportunity to Apply Principles During the COVID-19 Pandemic · Stephanie Parks Taylor · 2020 · 22 citations · Cited by this paper
  23. Review of Studies Evaluating Effectiveness of Risk Minimization Measures Assessed by the European Medicines Agency Between 2016 and 2021 · Renske J. Grupstra · 2023 · 20 citations · Cited by this paper
  24. Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review · Andrea M. Russell · 2020 · 17 citations · Cited by this paper
  25. Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014–2018) · Linda My Huynh · 2021 · 17 citations · Cited by this paper
  26. Adaptation for Regulatory Application: A Content Analysis of FDA Risk Evaluation and Mitigation Strategies Assessment Plans (2014–2018) Using RE-AIM · Gita A. Toyserkani · 2020 · 15 citations · Cited by this paper
  27. The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE) · Meredith Y. Smith · 2024 · 12 citations · Cited by this paper
  28. Pharmacovigilance processes in low- and middle-income countries: moving from data collection to data analysis and interpretation · Olga Menang · 2025 · 8 citations · Cited by this paper
  29. Development of a multicomponent implementation strategy to reduce upper gastrointestinal bleeding risk in patients using warfarin and antiplatelet therapy, and protocol for a pragmatic multilevel randomized factorial pilot implementation trial · Jacob E. Kurlander · 2022 · 8 citations · Cited by this paper
  30. Personalized medicine to implementation science: Thiopurines set for the leap · Vishal Sharma · 2022 · 8 citations · Cited by this paper
  31. The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System · Priya Bahri · 2024 · 7 citations · Cited by this paper
  32. Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study · Mathias Møllebæk · 2024 · 6 citations · Cited by this paper
  33. Risk Minimisation Evaluation with Process Indicators and Behavioural or Health Outcomes in Europe: Systematic Review · Esther Artime · 2020 · 5 citations · Cited by this paper
  34. Promoting safe and appropriate use of miltefosine to treat tegumentary leishmaniasis in Brazil: a best practice implementation project · Sarah Nascimento Silva · 2024 · 4 citations · Cited by this paper
  35. Using Mixed Methods to Evaluate Risk Minimisation Programs in Europe and the USA: An Innovative Blueprint · Meredith Y. Smith · 2025 · 4 citations · Cited by this paper
  36. REMS Logic Model: A Pragmatic Framework for Incorporating Drug Safety into Clinical Practice · Gita A. Toyserkani · 2025 · 3 citations · Cited by this paper
  37. Advances in Drug Safety: Highlights from the 23rd Annual Meeting of the International Society of Pharmacovigilance · Omar Aimer · 2024 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)